Unlock instant, AI-driven research and patent intelligence for your innovation.

Cefdinir dispersible tablet

A technology for cefdinir and dispersible tablets, applied in the field of oral preparations, can solve the problems of increasing the complexity of the preparation process, reducing the strength of the tablet body, swelling and dispersing, etc., and achieves high disintegration speed and effective ingredient dissolution speed. Poor thermal performance, the effect of improving moisture and heat resistance

Active Publication Date: 2021-04-09
TIANJIN CENT PHARM CO LTD
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, in practical applications, we have found that in hot and humid environments, the cefdinir dispersible tablets made by direct powder compression will absorb moisture for a short time after being taken out of the sealed package, resulting in a rapid decrease in tablet strength even swell
In this case, if the user takes out the medicine for some reason and does not take it temporarily, the taken out medicine will be discarded. The traditional anti-deliquescence measures are to add excipients such as cyclodextrin to prevent deliquescence, or to pack it after granulation. coating, but these measures themselves will increase the complexity of the preparation process, and will have adverse effects on the disintegration rate and dissolution rate of the dispersible tablet

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cefdinir dispersible tablet
  • Cefdinir dispersible tablet
  • Cefdinir dispersible tablet

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0010] The preparation technology of the cefdinir dispersible tablet provided by the invention comprises the following steps:

[0011] Preparation of pretreatment crospovidone: Povidone (PVP) K30 is dissolved in absolute ethanol to make a PVP solution with a weight percent concentration of 2.5%, and PVP will be mixed with PVP in a ratio of 1:10 by weight of PVP and PVPP. Solution is mixed with PVPP and then spray-dried to obtain pretreatment crospovidone (pretreatment PVPP);

[0012] Screening: pass the raw and auxiliary materials through a 40-mesh sieve for later use, to prevent the agglomeration of the raw materials and various auxiliary materials during the placement process

[0013] Mixing: put crospovidone and pretreated crospovidone, and cefdinir, micronized silica gel, aspartame, and microcrystalline cellulose in the prescribed amount into the square cone mixer in turn, and mix for 20 minutes Then add the prescribed amount of magnesium stearate and continue mixing for ...

Embodiment 1

[0019] Pharmacological Example 1, Uniformity of Dispersion Test

[0020] Test method: Take 6 cefdinir dispersible tablets prepared in Examples and Comparative Examples, place them in 100ml water in a 250mL beaker and shake them respectively. At a temperature of about 20°C, they should be completely disintegrated and uniformly dispersed in 3 minutes. State, through the No. 2 sieve, the test results are shown in the table below.

[0021]

[0022] Experimental result shows, although the dispersible tablet provided by embodiment and comparative example all can disintegrate within 3min, but the dispersion time of comparative example 3 is significantly higher than remaining examples, shows that the ratio that the pretreatment crospovidone adds is too high High will have adverse effects on the disintegration speed and dispersion uniformity of cefdinir dispersible tablets. And when the proportion of pretreated crospovidone is 30-70%, the obtained dispersible tablets can also be ra...

Embodiment 3

[0027] Pharmacological Example 3, high temperature and high humidity environment experiment

[0028] Get the dispersible tablet sample that embodiment and comparative example make, every group of 20, put watch glass through under condition is high humidity RH90% (40 ℃) condition, in 1h, 2h, 4h, 8h respectively, each sampling 5 Calculate the average moisture absorption weight gain rate of the sample, because it was found in the previous experiment that when the dispersible tablet absorbs moisture to a weight gain of more than 5%, the tablet body expands more obviously and the strength decreases obviously, so the weight gain rate exceeds 5% as the end of the experiment condition. Experimental result is as follows table (unit %):

[0029]

[0030] Experimental results show that the weight gain of the dispersible tablet obtained in Example 1 is lower than 5% at 4 hours, while the weight gain of the dispersible tablet obtained in Examples 3-4 can be kept lower than 5% at 8 hour...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a cefdinir dispersible tablet. The prescription of the cefdinir dispersible tablet comprises the following components in parts by weight: 80-120 parts of cefdinir, 0.5-1 part of a flavoring agent, 50-70 parts of polyvinylpolypyrrolidone serving as a disintegrating agent, 100-150 parts of microcrystalline cellulose serving as a filling agent, 3-8 parts of a lubricating agent and 3-8 parts of a flow aid. The polyvinylpolypyrrolidone accounting for 30-70 percent of the prescription amount is prepared into pretreated polyvinylpolypyrrolidone. A preparation method of the pretreated polyvinylpolypyrrolidone comprises the following steps of: dissolving povidone K30 into absolute ethyl alcohol to prepare a povidone solution with the weight percent of 2-3 percent; and mixing the povidone solution with the polyvinylpolypyrrolidone according to a weight ratio of the povidone to the polyvinylpolypyrrolidone of 1: (8-12), and performing spray drying to obtain the pretreated polyvinylpolypyrrolidone.

Description

technical field [0001] The invention relates to an oral preparation, in particular to an oral preparation with cefdinir as an active ingredient. Background technique [0002] Cefdinir (cefdinir, CAS: 91832-40-5) is an oral third-generation cephalosporin, which has the advantages of broad antibacterial spectrum and low toxicity. dissolve. The existing cefdinir oral preparations mainly include capsules and dispersible tablets, among which the dispersible tablet form has become the focus of current research on cefdinir preparations because of its convenience in taking, rapid disintegration, fast absorption and high bioavailability . Since cefdinir belongs to β-lactam antibiotics, it is easy to decompose and produce impurities under humid and hot conditions, and the dispersible tablet form needs to meet the requirements of rapid disintegration, so the existing cefdinir dispersible tablets generally adopt powder direct compression technology preparation. However, in practical...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/20A61K31/546A61K47/32A61K47/38A61P31/04
CPCA61K31/546A61K9/2027A61K9/2054A61K9/2095A61P31/04
Inventor 刘遵利李彤彤孟宪娣张曦赵凤闫崇国邢刚孙金龙
Owner TIANJIN CENT PHARM CO LTD